Panel wants regulations for genetic tests

Jan 18, 2008

A federal panel contended that regulations for genetic testing have not advanced with the growing number of consumers who buy them.

The panel, named the Secretary's Advisory Committee on Genetics, Health and Society, argued that the increasing amount of genetic trials have been advertised with unproved claims and could be deceptive, The New York Times reported Friday. The panel is part of the Department of Health and Human Services.

Cancer, diabetes, heart failure, and cystic fibrosis are among the conditions the tests claim to inform at risk patients of.

The panel warns that inaccurate test results given by doctors who lack experience with them could cause harm to sick patients in need of correct treatment.

"We would welcome more federal regulation. It's unclear what regulatory requirements apply to our products," Sciona Chief Science Officer, Rosalynn D. Gill said of the company, which conducts "nutrigenetic tests" over the internet.

The panel wrote in a report that test providers lack requirements for information disclosure to support their claims and that proof of their value is rare.

Copyright 2008 by United Press International

Explore further: German firm wins appeal in Spain thalidomide case

add to favorites email to friend print save as pdf

Related Stories

RCas9: A programmable RNA editing tool

Oct 03, 2014

A powerful scientific tool for editing the DNA instructions in a genome can now also be applied to RNA, the molecule that translates DNA's genetic instructions into the production of proteins. A team of researchers ...

Seeds to skyscrapers

Jun 25, 2014

Wood is one of the oldest building materials but its use is limited by its properties. With new funding, researchers aim to stretch these properties to an unprecedented degree, creating the means to build ...

Building synthetic plants

Jun 20, 2014

A movement is under way that will fast-forward the design of new plant traits. It takes inspiration from engineering and the software industry, and is being underpinned in Cambridge and Norwich by an initiative ...

Recommended for you

German firm wins appeal in Spain thalidomide case

1 hour ago

A Spanish court has upheld an appeal by a German pharmaceutical company, ditching a previous ruling that ordered the company to pay compensation to 22 Spaniards who blame their disabilities on the drug thalidomide.

New MCAT shifts focus, will include humanities

Oct 20, 2014

(HealthDay)—The Medical College Admission Test (MCAT) has been revised, and the latest changes, including more humanities such as social sciences, are due to be implemented next April, according to a report ...

User comments : 0